Leukemia: Fact Sheet for Patients
Almost everyone has heard of leukemia, but most people do not have a good understanding of this complex disease. How can healthcare providers explain the basics of leukemia to their patients?
News
Strategy for Assessing Axillary Adenopathy on Mammography Following COVID-19 Vaccination
A team of radiologists explain their strategy for maintaining breast cancer screening in women with managing a potential side effect of vaccination.
Nomogram Developed to Guide Management of Thin Melanomas
Using readily available clinicopathologic information, a team of investigators developed a risk calculator to predict disease recurrence in patients with thin melanomas.
Descartes-11 Trial Tests RNA-Engineer Cell Therapy in Multiple Myeloma
Cartesian Therapeutics launches a trial of Descartes-11, which is designed to express CAR-T molecules transiently.
Lorbrena Approved for First-Line Treatment of ALK-Positive Metastatic NSCLC
Lorbrena is a third generation ALK tyrosine kinase inhibitor.
Survey Responses Reveal Focus of Cancer Survivors’ Pandemic-Related Worries
A survey conducted in the early months of the pandemic revealed cancer survivors’ greatest concerns regarding their care, prognosis, and finances.
Palliative Care Considered Beneficial, Though Infrequently Used in Lung Cancer
A team of international investigators deployed a survey to understand the needs of patients with EGFR-positive lung cancer community.
Novel Therapy for Diffuse Intrinsic Pontine Glioma Fast Tracked
Oblato plans to evaluate OKN-007 for diffuse intrinsic pontine glioma in a phase 1/2 trial this year.
Cavrotolimod Designated Orphan Drug for Merkel Cell Carcinoma
Cavrotolimod is a toll-like receptor 9 agonist that is designed to induce anticancer immune responses through proprietary spherical nucleic acid (SNA™) technology.
COVID-19 Pandemic Hampering Launch of New Oncology Trials
A team of researchers conducted a study to assess the impact of the COVID-19 pandemic on the initiation of clinical trials in oncology.
Bleeding Disorders: What Your Patients Need to Know
Whether inherited or acquired, bleeding disorders can cause significant pain, inconvenience, and stress in a person’s life. When patients think they or a loved one may have a bleeding disorder, what should they know?
Review Shows Evidence of Link Between Diet, Colorectal Cancer Risk
A review of meta-analyses sought to grade the evidence related to associations between dietary factors and colorectal cancer risk.
Cosela Now Available to Reduce Chemotherapy-Induced Bone Marrow Suppression in ES-SCLC
The approval was based on data from 3 randomized, placebo-controlled trials that included 245 adults with ES-SCLC.
Keytruda Indication for Metastatic Small Cell Lung Cancer Withdrawn
Continued approval of the indication was contingent upon establishing the superiority of Keytruda as determined by overall survival.
Carboplatin Plus Nab-Paclitaxel and RT Promising for Advanced NSCLC in the Elderly
A team of investigators sought to determine outcomes from combination low-dose carboplatin plus nab-paclitaxel with concurrent radiotherapy among elderly patients with advanced non-small cell lung cancer.
Presence of Diabetes and Risks for Anemia, Infection in Colorectal Cancer Survivors
A retrospective study of electronic health records sought to determine the effect of presence of diabetes on long-term outcomes for colorectal cancer survivors.
Most Patients With Breast, Ovarian Cancer Patients Do Not Undergo Genetic Testing
The number of genes tested for ovarian and breast cancer has grown, but most patients do not undergo testing, and variant-of-unknown-significance results are common, especially among minority populations.
Patient-Reported Outcomes With Lorlatinib in NSCLC
Although patient-reported outcomes measures were similar with lorlatinib and crizotinib in non-small cell lung cancer, more patients reported improvement in symptoms with lorlatinib.
Preexisting Autoimmune Disease Increases Incidence of irAEs With PD-1 Immunotherapy for Advanced Cancer
Study findings demonstrate the rates of immune-related adverse events and flares of the underlying disorders in this patient population.
Janssen’s Single-Shot COVID-19 Vaccine Gets Emergency Use Authorization
The EUA was based on data from the randomized, double-blind, placebo-controlled ENSEMBLE trial.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Web Exclusives
